TrialChinese journal of integrative medicine2022
Patients with Metastatic Colorectal Cancer after Failure of Second-Line Treatment May Benefit from Low-Dose Apatinib and S-1 Combined with Jianpi Bushen Jiedu Decoction.
Yue Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.